Overview

• Health Canada issued the recall on June 20, 2025, covering Acuvue Oasys Max 1-day Multifocal contact lenses sold nationwide.
• Johnson & Johnson Vision Care identified a high density of microbubbles in certain lens batches that may cause visual disturbances in low-light settings.
• The department classified the action as a type II recall, signaling potential temporary adverse effects or a remote chance of serious harm.
• The recall applies to multiple lot and model numbers and consumers should check their packaging against Health Canada’s list.
• Canadians with the affected lenses are urged to contact the manufacturer for information, following last year’s Total1 and Total30 lens recall.